The difference between the credibility and the unambiguous disclosure of a therapeutic effect (T 0209/22)
The IPKat
JUNE 2, 2024
The patent did not include any patient data for the drug combination. The prior art included a summary of the phase I clinical trial protocol. It is also possible to patent the second medical use of a known drug, e.g. in a different disease or at a different dose ( Article 54(4) EP ).
56 
Let's personalize your content